 Treatment psoriatic arthritis oral pilot study open-label trial patients active psoriatic arthritis micrograms oral Statistically significant improvement tender joint count physician global impression patients substantial equal improvement moderate equal improvement tender joint count patients unable therapeutic doses hypercalciuria High-dose vitamin useful therapeutic agent psoriatic arthritis